{
    "nct_id": "NCT06348147",
    "official_title": "An Attenuated Schedule Dara-RVd Induction for Patients With Newly Diagnosed Multiple Myeloma Who Are Eligible for Autologous Stem Cell Transplantation",
    "inclusion_criteria": "1. Written informed consent was obtained to participate in the study and HIPAA authorization for release of personal health information. Subjects are willing and able to comply with study procedures based on the judgment of the investigator.\n2. Age ≥18 years at the time of consent.\n3. Eastern Cooperative Oncology Group (ECOG) ≤ 2\n4. Subjects with Multiple Myeloma.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Active infection requiring systemic therapy or other serious infection within 14 days prior to study treatment.\n2. Pregnant or breastfeeding.",
    "miscellaneous_criteria": ""
}